Company plans to meet with the FDA to align on registrational trial designs in 1H25 based on emerging clinical profile of resecabtagene ...
Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 30,141.70 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...